Cargando…

2381. Epidemiology of Clostridium difficile Infection in Patients Receiving Interleukin-2 Therapy

BACKGROUND: Clostridium difficile infection (CDI) has been associated with interleukin-2 (IL2) therapy, possibly leading to unnecessary testing and treatment of colonized patients receiving IL2 therapy. Since the debut of IL2 therapy for renal cell carcinoma (RCC) and metastatic melanoma (MM), only...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Aldon, Nguyen, Nga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809734/ http://dx.doi.org/10.1093/ofid/ofz360.2059

Ejemplares similares

525 Epidemiology and burden of recurrent Clostridium difficile infections
por: Sheitoyan-Pesant, Caroline, et al.
Publicado: (2014)

2392. Identifying Associations Between Clostridium difficile Infection Incidence and Cancer Patients Receiving Chemotherapy
por: Louie Mendiola, Vincent, et al.
Publicado: (2019)

Clostridium difficile Molecular Epidemiology in a Prospective Cohort of Canadian Children Compared with Cases of C. difficile Infection
por: Lloyd, Colin, et al.
Publicado: (2017)

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)

2401. Epidemiology of Clostridium difficile Infection in Intestinal and Multivisceral Transplant Patients at a Single Transplant Center
por: Modi, Anita R, et al.
Publicado: (2019)

Epidemiology and Outcomes of Clostridium difficile Infection in Hospitalized Patients within the US Military Health Care System
por: Eberly, Matthew, et al.
Publicado: (2017)

Epidemiology of Clostridium difficile infection in Asia
por: Collins, Deirdre A, et al.
Publicado: (2013)

The Impact of Diagnostic Stewardship on Clostridium difficile Infections
por: Bischoff, Werner, et al.
Publicado: (2017)

1593. Recurrence of Clostridium difficile Infection in Multiple Myeloma Patients Receiving Prophylactic Oral Vancomycin or Oral Metronidazole vs. No Prophylaxis
por: Moran, Gisele, et al.
Publicado: (2018)

Current Status of Clostridium difficile Infection Epidemiology
por: Lessa, Fernanda C., et al.
Publicado: (2012)

Epidemiology of Clostridium difficile infection Among Patients with Newly Diagnosed or Relapsed Acute Leukemia: A Single-center Experience
por: Garcia, Alexandra Franco, et al.
Publicado: (2017)

2673. Risk Factors for Clostridium difficile Infection in Lung Transplant Patients
por: DeRose, Joseph L, et al.
Publicado: (2019)

483. Clinical Characteristics of Military Trauma Patients With Clostridium difficile Infections
por: Schall, Sarah, et al.
Publicado: (2018)

2381. Ceftolozane/Tazobactam in the Treatment of Experimental Pseudomonas aeruginosa Pneumonia in Persistently Neutropenic Rabbits: Impact on Strains With Genetically Defined Resistance
por: Petraitis, Vidmantas, et al.
Publicado: (2018)

1646 Evidence of hospital-associated Clostridium difficile transmission between patients with asymptomatic carriage and patients with Clostridium difficile infection
por: Galdys, Alison, et al.
Publicado: (2014)

2381 Childhood adversity, attachment style, and home visiting engagement
por: Bower, Kelly M., et al.
Publicado: (2018)

Epidemiologic Trends in Clostridium difficile Isolate Ribotypes in United States from 2010 to 2014
por: Snydman, David R, et al.
Publicado: (2017)

445 Epidemiology and Outcomes of Clostridium difficile Infections in Heart and Heart-lung Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

Risk Factors for Community-Associated Clostridium difficile Infection in Children
por: Weng, Mark, et al.
Publicado: (2017)

1889. A Clinical Practice Assessment on Clostridium difficile Infection
por: Lubarda, Jovana, et al.
Publicado: (2018)

468. Diagnosis of Clinical Clostridium difficile Infection: An Unmet Challenge
por: Vyas, Neeti, et al.
Publicado: (2018)

511. What Is the Current State of Patient Education after Clostridium difficile Infection?
por: DeBenedictus, Christina, et al.
Publicado: (2018)

507. Degree of Concordance of Clostridium difficile Strains in Adults with Community-Associated C. difficile Infection and Infants With C. difficile Colonization
por: Clayton, Jason A, et al.
Publicado: (2018)

519. Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection
por: Yi, Sarah H, et al.
Publicado: (2018)

779. Impact of updated IDSA practice guidelines on the treatment of Clostridium difficile infections in the United States
por: Clancy, Cornelius J, et al.
Publicado: (2019)

Molecular epidemiology of Clostridium difficile infection in Iranian hospitals
por: Shoaei, Parisa, et al.
Publicado: (2019)

The Epidemiology and Economic Burden of Clostridium difficile Infection in Korea
por: Choi, Hyung-Yun, et al.
Publicado: (2015)

Prevalence and molecular epidemiology of Clostridium difficile infection in Thailand
por: Putsathit, P., et al.
Publicado: (2016)

Prevalence and molecular epidemiology of Clostridium difficile infection in Indonesia
por: Collins, D.A., et al.
Publicado: (2017)

Rational Therapy of Clostridium difficile Infections
por: Keller, Peter M., et al.
Publicado: (2014)

2365. Volatile Metabolite-Based Detection of Clostridium difficile Infection (CDI)
por: Aloum, Obadah, et al.
Publicado: (2019)

Association of Acid Suppression and Antimicrobial Use with Clostridium difficile Infection in Children
por: Huynh, Hoang A, et al.
Publicado: (2017)

Risk Factors for Recurrent Pedatric Community Associated Clostridium difficile Infection
por: Parmar, Deepika, et al.
Publicado: (2017)

External validation of predictive scores for mortality following Clostridium difficile infection
por: Beauregard-Paultre, Catherine, et al.
Publicado: (2017)

External validation of clinical scores to predict complications of Clostridium difficile infection
por: Beauregard-Paultre, Catherine, et al.
Publicado: (2017)

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)

490. Comparison of Clostridium difficile Infection Outcomes by Diagnostic Testing Method
por: Guh, Alice, et al.
Publicado: (2018)

2422. Effectiveness of a Probiotic for Primary Prevention of Clostridium difficile Infection and Antibiotic-Associated Diarrhea among Hospitalized Patients Receiving Broad-Spectrum Antibiotics
por: Le, Khanh-Linh, et al.
Publicado: (2019)

514. The Effect of Probiotics on the Incidence of Clostridium difficile
por: Saltzman, Temima, et al.
Publicado: (2018)

1501. Risk Factors for Clostridium difficile Infection in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c52f2tq639f9vnkdqvhgt5tgut